ADVANCED HEMP SCIENCE
Every compound has a scientific story.
Explore the cannabinoids in GREENLION profiles, the questions researchers ask and the limits of the evidence.
Cannabidiol
The major cannabinoid in the line. Clinical literature is broader than for minor cannabinoids, but any effect depends on formulation, dose and clinical context.
Explore further ↗Minor cannabinoidCBGCannabigerol
A minor cannabinoid. Experimental studies investigate inflammatory and neurological pathways; clinical evidence remains limited.
Explore further ↗Minor cannabinoidCBNCannabinol
A rare cannabinoid investigated in clinical sleep studies. Findings vary with the dose and formulation studied, and cannot be generalized to every product.
Explore further ↗Minor cannabinoidCBCCannabichromene
A rare cannabinoid. Experimental studies investigate pathways related to inflammation and nociception; this is not a treatment indication.
Explore further ↗Minor cannabinoidCBLCannabicyclol
A rare cannabinoid. A 2025 experimental study investigated its interaction with the serotonin 5-HT1A receptor. This does not demonstrate clinical efficacy or establish effects of the formulation.
Explore further ↗Varinic cannabinoidCBDVCannabidivarin
A rare varin cannabinoid investigated in exploratory clinical studies. Evidence of its effects in humans remains limited.
Explore further ↗Acidic formCBG-ACannabigerolic acid
An acidic form and precursor to other cannabinoids. It is a rare compound, still studied mainly in experimental models.
Explore further ↗Acidic formCBD-ACannabidiolic acid
The acidic form of CBD, investigated in experimental models involving serotonin 5-HT1A receptors. Clinical evidence remains limited.
Explore further ↗Acidic formCBC-ACannabichromenic acid
The acidic form of CBC. In vitro studies investigate its interaction with cellular transporters ABCG2 and ABCB1. Laboratory findings do not establish a clinical indication.
Explore further ↗Acidic formTHCATetrahydrocannabinolic acid
An acidic cannabinoid investigated in cellular and animal models involving PPARγ. Experimental findings do not establish a clinical indication.
Explore further ↗Varinic cannabinoidTHCVTetrahydrocannabivarin
A rare varin cannabinoid studied in pilot trials of metabolic parameters. The findings are preliminary and require confirmation in larger studies.
Explore further ↗Potentially psychoactive cannabinoidΔ8-THCDelta-8-tetrahydrocannabinol
A cannabinoid with psychoactive potential and regulatory relevance. Confirm concentration in the lot COA and with the prescriber.
Explore further ↗Potentially psychoactive cannabinoidΔ9-THCDelta-9-tetrahydrocannabinol
A cannabinoid with psychoactive potential and regulatory relevance. Confirm concentration in the lot COA and with the prescriber.
Explore further ↗Aromatic compoundsTerpenesTerpenes
Not cannabinoids. They are aromatic compounds in the formulation profile; confirm their presence in the lot COA.
Explore further ↗